This is Joint Academy

Joint Academy is a healthcare provider, based on science and technology, which delivers a digital first-line treatment for osteoarthritis. Joint Academy combines contact with a physiotherapist, personalised activities, and education about the disease. The fact that the treatment is digital, contributes to making healthcare more scalable and efficient.

Science

Joint Academy’s treatment is based on published, scientific studies and extensive experience from specialists in osteoarthritis – which show in our patient’s results.

Technology

The combination of digital treatment and data science opens up new possibilities of treating chronic conditions, in a sustainable and more personalised way.

Empathy

Joint Academy always puts the patient first. Our experts are available and ready to help before, during, and after the treatment.

We stand behind the company

Joint Academy AB was founded by father and son, Leif and Jakob Dahlberg, in 2014. At the time, Jakob studied Computer Science while Leif continued his leading research on osteoarthritis. Jakob saw an opportunity to scale up his father’s research to a global level with the help of software. He then started putting the puzzle, that was to become Joint Academy, together.

Today, the team at Joint Academy consists of more than 40 people with various backgrounds that all work to make the world’s first successful digital osteoarthritis treatment available for millions of people and, with that, improve lives all over the world.

World-leading medical competence

Leif Dahlberg, Chief Medical Officer

Leif Dahlberg is a professor in orthopedics and has more than 25 years of experience of research in cartilage and joints. His current research involves the cartilage on a molecular level, MRI, and clinical work focused on epidemiology. Dahlberg has published more than 100 peer-reviewed scientific studies and has been cited close to 3000 times.

Stefan Lohmander, Professor, MD, PhD

Stefan Lohmander, MD and PhD, is an international expert based at Lund University. Lohmander has focused on understanding relevant ways of observing the progression of osteoarthritis as well as the causations of the condition. Lohmander’s lifelong commitment has always been centered around improving osteoarthritis treatment while also improving the individual’s quality of life.